JP2019531344A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019531344A5 JP2019531344A5 JP2019535993A JP2019535993A JP2019531344A5 JP 2019531344 A5 JP2019531344 A5 JP 2019531344A5 JP 2019535993 A JP2019535993 A JP 2019535993A JP 2019535993 A JP2019535993 A JP 2019535993A JP 2019531344 A5 JP2019531344 A5 JP 2019531344A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- weight
- liquid
- crystals
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201611031045 | 2016-09-12 | ||
| IN201611031045 | 2016-09-12 | ||
| US201662412681P | 2016-10-25 | 2016-10-25 | |
| US62/412,681 | 2016-10-25 | ||
| PCT/IB2017/001312 WO2018047013A1 (en) | 2016-09-12 | 2017-09-12 | Formulations of 4-methyl-5-(pyrazin-2-yl)-3h-1, 2-dithiole-3-thione, and methods of making and using same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019531344A JP2019531344A (ja) | 2019-10-31 |
| JP2019531344A5 true JP2019531344A5 (https=) | 2020-11-05 |
Family
ID=60569947
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019535993A Pending JP2019531344A (ja) | 2016-09-12 | 2017-09-12 | ４−メチル−５−（ピラジン−２−イル）−３ｈ−１，２−ジチオール−３−チオンの処方物、ならびにそれらの製造方法及び使用方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US11426403B2 (https=) |
| EP (1) | EP3509642A1 (https=) |
| JP (1) | JP2019531344A (https=) |
| KR (1) | KR102658015B1 (https=) |
| CN (1) | CN109996562A (https=) |
| AU (1) | AU2017323504A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7930336B2 (en) | 2006-12-05 | 2011-04-19 | Altera Corporation | Large multiplier for programmable logic device |
| EP3509641A1 (en) * | 2016-09-12 | 2019-07-17 | ST IP Holding AG | Formulations of 4-methyl-5-(pyrazin-2-yl)-3h-1.2-dithiole-3-thione, taste-modified formulations, and methods of making and using same |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7067116B1 (en) | 2000-03-23 | 2006-06-27 | Warner-Lambert Company Llc | Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1 |
| JP2004515453A (ja) * | 2000-05-05 | 2004-05-27 | ウィスコンシン・アルムナイ・リサーチ・ファウンデーション | 癌を化学療法および放射線療法に付する間に細胞を保護するための組成物および方法 |
| US7012148B2 (en) | 2001-09-25 | 2006-03-14 | Trustees Of Dartmouth College | Compositions and methods for thionation during chemical synthesis reactions |
| US7199122B2 (en) | 2001-10-02 | 2007-04-03 | Fox Chase Cancer Center | Methods for inhibiting angiogenesis |
| US20050182128A1 (en) | 2002-02-13 | 2005-08-18 | Stephen Lam | Use of anethole dithiolethione in lung cancer chemoprevention |
| KR100491318B1 (ko) | 2002-11-26 | 2005-05-24 | 씨제이 주식회사 | 올티프라즈(Ｏｌｔｉｐｒａｚ) 제조방법 |
| PL1696958T3 (pl) | 2003-12-22 | 2007-08-31 | Alcon Inc | Środki do leczenia retinopatii jaskrowej i neuropatii wzrokowej |
| KR100629771B1 (ko) * | 2004-01-27 | 2006-09-28 | 씨제이 주식회사 | 결정성이 감소되거나 무정형화된 올티프라즈의 제조방법 |
| DK2377557T3 (en) * | 2004-11-24 | 2017-02-06 | Meda Pharmaceuticals Inc | Compositions comprising azelastine and methods for its use |
| FR2879444B1 (fr) | 2004-12-22 | 2007-05-18 | Oreal | Utilisation d'un compose capable d'augmenter le taux de glutathion dans les melanocytes pour le traitement de la canitie |
| US20070036733A1 (en) | 2005-08-12 | 2007-02-15 | Takasago International Corp. (Usa) | Sensation masking composition |
| ES2668361T3 (es) | 2005-08-15 | 2018-05-17 | Givaudan Sa | Compuestos refrigerantes |
| US7803353B2 (en) | 2006-03-29 | 2010-09-28 | The Procter & Gamble Company | Oral care compositions having improved consumer aesthetics and taste |
| GB0704718D0 (en) * | 2007-03-12 | 2007-04-18 | Prendergast Patrick T | Compounds and methods for preventing and treating mucositis |
| ATE540667T1 (de) | 2007-06-13 | 2012-01-15 | Givaudan Sa | Verbindungen mit kühlender wirkung |
| US20110003747A1 (en) | 2007-07-20 | 2011-01-06 | Coloumbe Pierre A | Use of nrf2 inducers to treat epidermolysis bullosa simplex and related diseases |
| EP2244699A2 (en) | 2008-01-31 | 2010-11-03 | Mcneil-PPC, Inc | Edible film-strips for immediate release of active ingredients |
| EP2265126A4 (en) | 2008-03-10 | 2011-06-29 | Univ Louisville Res Found | PROCESS AND COMPOSITIONS FOR THE CONTROLLED DELIVERY OF PHYTOCHEMICALS |
| US8858995B2 (en) | 2008-03-10 | 2014-10-14 | University Of Louisville Research Foundation, Inc. | Methods and compositions for controlled delivery of phytochemical agents |
| KR101057485B1 (ko) | 2008-08-04 | 2011-08-17 | 서울대학교산학협력단 | 1,2-디티올티온 유도체를 함유하는 엘엑스알-알파 과다발현으로 인한 질병의 예방 및 치료용 약학 조성물 |
| EP2427170A2 (en) | 2009-05-05 | 2012-03-14 | Givaudan SA | Organic compounds having cooling properties |
| CN102451469A (zh) * | 2010-10-26 | 2012-05-16 | 沈阳药科大学 | 一类用于难溶性药物纳米系统的高效稳定剂 |
| JP2014516080A (ja) | 2011-06-08 | 2014-07-07 | エスティーアイ ファーマ， エルエルシー | 一日一回の投与のための吸収が制御された水溶性の薬学的に活性な有機化合物製剤 |
| EP2757887B1 (en) | 2011-09-22 | 2017-04-26 | VIIV Healthcare UK Limited | Pyrrolopyridinone compounds and methods for treating hiv |
| BR112015014523A2 (pt) * | 2012-12-19 | 2017-07-11 | Kashiv Pharma Llc | nanossuspensão estabilizada, composição farmacêutica, e, método de tratamento de um paciente |
| US20160206641A1 (en) | 2013-08-16 | 2016-07-21 | Luminus Biosciences Inc. | Rapidly-dissolving thin film formulation of water soluble digitalis glycoside for the treatment of congestive heart disease |
| CN106029175A (zh) | 2014-02-27 | 2016-10-12 | 宝洁公司 | 具有减少的苦味感受的口腔护理组合物 |
| US20160376259A1 (en) * | 2015-06-25 | 2016-12-29 | St Ip Holding Ag | Methods for Preparing Oltipraz |
| WO2016207914A2 (en) | 2015-06-25 | 2016-12-29 | St Ip Holding Ag | Methods for preparing oltipraz |
| ITUB20159655A1 (it) | 2015-12-23 | 2017-06-23 | Bormioli Rocco Spa | Capsula di sicurezza di un contenitore. |
| ITUA20162141A1 (it) | 2016-03-31 | 2017-10-01 | Bormioli Pharma Spa | Capsula di chiusura |
| EP3509641A1 (en) * | 2016-09-12 | 2019-07-17 | ST IP Holding AG | Formulations of 4-methyl-5-(pyrazin-2-yl)-3h-1.2-dithiole-3-thione, taste-modified formulations, and methods of making and using same |
| KR20180123796A (ko) | 2017-05-10 | 2018-11-20 | 서울대학교산학협력단 | Nrf2-NEMO 경로 활성화를 통한 과중력으로 인한 세포괴사의 억제용 조성물 및 방법 |
-
2017
- 2017-09-12 JP JP2019535993A patent/JP2019531344A/ja active Pending
- 2017-09-12 EP EP17808567.6A patent/EP3509642A1/en active Pending
- 2017-09-12 CN CN201780069787.9A patent/CN109996562A/zh active Pending
- 2017-09-12 KR KR1020197010583A patent/KR102658015B1/ko active Active
- 2017-09-12 AU AU2017323504A patent/AU2017323504A1/en not_active Abandoned
-
2019
- 2019-03-12 US US16/351,058 patent/US11426403B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2903383T3 (es) | Preparación de complejos sólidos de ciclodextrina para la administración de un principio farmacéutico activo oftálmico | |
| US20200246278A1 (en) | Injectable diethylstilbestrol nanosuspension formulation | |
| JP5587198B2 (ja) | タキサン誘導体を含有する、安定性が改良された凍結乾燥医薬組成物、及びその製法 | |
| Kolawole et al. | Formulation and evaluation of paclitaxel-loaded boronated chitosan/alginate nanoparticles as a mucoadhesive system for localized cervical cancer drug delivery | |
| JP2013545752A5 (https=) | ||
| EP3993807B1 (en) | Method for stabilizing the ph of an aqueous composition comprising a drug | |
| JP2010510241A5 (https=) | ||
| Praphanwittaya et al. | Aqueous solubility of kinase inhibitors: I the effect of hydrophilic polymers on their γ-cyclodextrin solubilization | |
| CN108697683A (zh) | 口服紫杉烷组合物和方法 | |
| KR20210044245A (ko) | 주사가능 약학 조성물 및 이의 제조 방법 | |
| JP2020073564A5 (https=) | ||
| WO2022162158A1 (en) | Pharmaceutical composition comprising a diphenylpyrazine derivative | |
| AR098389A1 (es) | Complejos de fulvestrant y sus derivados, proceso para su preparación y composiciones farmacéuticas que los contienen | |
| CN114007588A (zh) | 比拉斯汀的稳定和保存的药物组合物 | |
| Öztürk et al. | Mixed micelles formulation for carvedilol delivery: In-vitro characterization and in-vivo evaluation | |
| JP2019531344A5 (https=) | ||
| JP6666352B2 (ja) | デュタステリド含有固体分散体及びこれを含む組成物 | |
| US20240058358A1 (en) | Ph stabilized topical ophthlamic compositions | |
| JP2019533008A5 (https=) | ||
| WO2022061120A1 (en) | Solid dispersions containing amorphous nintedanib, their synthesis and use thereof | |
| TW201922250A (zh) | 比拉斯汀（ｂｉｌａｓｔｉｎｅ）的水性組成物 | |
| US20170231981A1 (en) | Compositions of multiple aripiprazole prodrugs | |
| ES2721270T5 (es) | Composiciones de profármaco de aripiprazol | |
| JP2007016024A (ja) | ロフルミラスト点眼液 | |
| JP2024532885A (ja) | 医薬組成物及びその調製方法 |